Are Statistical Analysis Plans “required” for Pivotal Studies? [General Sta­tis­tics]

posted by Achievwin – US, 2023-02-15 13:07 (814 d 08:20 ago) – Posting: # 23467
Views: 3,485

❝ Dear colleagues, we are conducting a pivotal fed-fasted BE study versus a reference listed drug (RLD).


Here is my opinion:

Essentially it is your study and you have to defend the submission, it is your prerogative to have what you want. - CRO gets most of their money when they deliver draft report (study pass/fail)

If it is a complex study - you have to predefine critical steps in the SAP (before the sample analysis start- to avoid any claims of Bias).

If it is a study against the product specific guidance and logical analysis is easy to understand you can refer to the FDA guidance(s) in the protocol.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
136 visitors (0 registered, 136 guests [including 10 identified bots]).
Forum time: 22:28 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5